Renvela Tablet (Sevelamer Carbonate Tablet) 800mg

Renvela Tablet 800mg contains sevelamer carbonate, a phosphate binder used to manage high phosphate levels in adults with chronic kidney disease. This medication helps maintain balanced mineral levels in the body. Suitable for ambient storage, it comes in a 180-tablet pack. Ideal for phosphate control in kidney care routines.

Strength

800mg

Pack Size

180s

Storage

Ambient

Manufacturer / TM Owner

SANOFI B.V.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sevelamer carbonate, the active ingredient in Renvela Tablet 800mg, is primarily used to treat high phosphate levels in people with chronic kidney disease. It works by binding dietary phosphate in the digestive tract, reducing absorption. This medication is often prescribed when phosphate levels remain high despite dietary restrictions. It supports overall mineral balance in kidney patients.

Side Effects

Renvela Tablet 800mg may help reduce symptoms associated with elevated phosphate levels, such as itching or bone discomfort. Users often report improved comfort when phosphate levels are managed effectively. It is designed to be taken with meals for optimal phosphate binding. Individual responses may vary based on dietary habits and kidney function.

Precautions & Warnings

Store Renvela Tablet 800mg at room temperature, away from moisture and heat. Swallow tablets whole; do not crush, chew, or split unless advised by a healthcare professional. Take with meals to enhance effectiveness. Keep out of reach of children and pets. Consult a doctor if you experience persistent digestive discomfort.

Avoid Interactions

Renvela Tablet 800mg may interact with medications that require acidic conditions for absorption, such as certain antibiotics or thyroid hormones. Separate dosing by at least one hour to minimize interaction risks. Avoid taking with high-fat meals, as they may reduce effectiveness. Always inform your healthcare provider about all medications being taken.

Frequently Asked Questions

Renvela Tablet 800mg is used to control high phosphate levels in adults with chronic kidney disease.

Take Renvela Tablet 800mg with meals as directed by your healthcare provider. Swallow whole with water.

Do not crush, chew, or split Renvela Tablet 800mg unless advised by a healthcare professional.

Common effects may include digestive discomfort, nausea, or vomiting. Report persistent issues to a healthcare provider.

Renvela Tablet 800mg is prescribed for ongoing phosphate management under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.